Straumann Holding AG (OTCMKTS:SAUHY) Short Interest Update

Straumann Holding AG (OTCMKTS:SAUHYGet Free Report) was the recipient of a significant growth in short interest during the month of April. As of April 15th, there was short interest totaling 36,373 shares, a growth of 9,226.4% from the March 31st total of 390 shares. Based on an average trading volume of 325,187 shares, the short-interest ratio is currently 0.1 days. Approximately 0.0% of the company’s shares are short sold.

Straumann Trading Up 0.8%

SAUHY opened at $10.81 on Friday. Straumann has a one year low of $9.44 and a one year high of $14.18. The business’s 50 day moving average price is $10.94 and its 200 day moving average price is $11.57.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on SAUHY shares. Morgan Stanley reiterated an “underweight” rating on shares of Straumann in a report on Tuesday, April 14th. Citigroup reiterated a “sell” rating on shares of Straumann in a report on Thursday. One analyst has rated the stock with a Buy rating, two have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Reduce”.

Get Our Latest Analysis on Straumann

About Straumann

(Get Free Report)

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.

Read More

Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.